OLIVIERI, GIULIO
 Distribuzione geografica
Continente #
NA - Nord America 317
EU - Europa 191
AS - Asia 72
AF - Africa 8
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 591
Nazione #
US - Stati Uniti d'America 312
IT - Italia 117
SE - Svezia 31
SG - Singapore 28
IN - India 27
BG - Bulgaria 10
TG - Togo 7
CA - Canada 4
GB - Regno Unito 4
IE - Irlanda 4
SA - Arabia Saudita 4
BE - Belgio 3
DE - Germania 3
RO - Romania 3
BR - Brasile 2
FI - Finlandia 2
HK - Hong Kong 2
HR - Croazia 2
KZ - Kazakistan 2
NL - Olanda 2
RS - Serbia 2
TH - Thailandia 2
TR - Turchia 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
CH - Svizzera 1
CN - Cina 1
ES - Italia 1
EU - Europa 1
FR - Francia 1
IQ - Iraq 1
JP - Giappone 1
LI - Liechtenstein 1
MK - Macedonia 1
MX - Messico 1
PH - Filippine 1
TN - Tunisia 1
Totale 591
Città #
Chandler 45
Rome 35
Fairfield 33
San Paolo di Civitate 24
Ashburn 18
Singapore 16
Milan 14
Wilmington 14
Princeton 13
Lawrence 12
San Diego 11
Sofia 10
Woodbridge 10
Ann Arbor 9
Boston 9
Cambridge 9
Houston 9
Andover 8
Millbury 8
New York 8
Lomé 7
Seattle 5
Dublin 4
Jeddah 4
Savona 4
Naples 3
Ancona 2
Bangkok 2
Brussels 2
Bursa 2
Charlottesville 2
Chennai 2
Fisciano 2
Hong Kong 2
Montréal 2
Norwalk 2
Ridder 2
San Jose 2
Sesto Fiorentino 2
Stockholm 2
Toronto 2
Turin 2
West Jordan 2
Amsterdam 1
Baghdad 1
Bari 1
Bremen 1
Buffalo 1
Casatenovo 1
Castelfidardo 1
Dubai 1
Edinburgh 1
Fortaleza 1
Fremont 1
Frosinone 1
Helsinki 1
Hyderabad 1
Lappeenranta 1
Las Piñas 1
Madrid 1
Manchester 1
Mannheim 1
Mexico City 1
Mountain View 1
Mumbai 1
Nuremberg 1
Palermo 1
Prescot 1
Redwood City 1
San Floriano del Collio 1
Santa Cruz 1
Tokyo 1
Tunis 1
Utrecht 1
Vittuone 1
Totale 408
Nome #
Comprehensive disease control in systemic lupus erythematosus 63
OP0204 LUPUS COMPREHENSIVE DISEASE CONTROL IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: APPLICATION OF A NEW INDEX 60
Five-years drug survival of mycophenolate mofetil therapy in patients with systemic lupus erythematosus. comparison between renal and non-renal involvement 51
Genetic diversity of staphylococcus aureus influences disease phenotype of systemic lupus erythematosus 46
Caffeine intake influences disease activity and clinical phenotype in systemic lupus erythematosus patients 45
Systemic lupus erythematosus before and after COVID-19 Lockdown. how the perception of disease changes through the lenses of narrative medicine 45
CAFFEINE INTAKE MODULATES DISEASE ACTIVITY AND CYTOKINES LEVELS IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS 41
Immune checkpoint inhibitors and pre-existing antinuclear antibodies: the rheumatologist point of view 39
Staphylococcus aureus nasal carriage and autoimmune disease. from pathogenic mechanisms to disease susceptibility and phenotype 34
Joint involvement influences quality of life in systemic lupus erythematosus patients 33
FRI0159 EROSIVE ARTHRITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS: APPLICATION OF CLUSTER ANALYSIS 32
SARS-CoV-2 vaccination efficacy and B-cell depletion therapy in systemic lupus erythematosus. description of a case 29
Development of systemic autoimmune diseases in healthy subjects persistently positive for antiphospholipid antibodies. long-term follow-up study 27
Belimumab is able to induce a significant improvement of joint activity status in patients diagnosed with systemic lupus erythematosus. results from a 12-month longitudinal study 22
Can machine learning models support physicians in systemic lupus erythematosus diagnosis. results from a monocentric cohort 19
Rheumatic Diseases Development in Patients Treated by Anti-PD1 Immune Checkpoint Inhibitors: A Single-Centre Descriptive Study 17
Erosive arthritis in systemic lupus erythematosus: not only Rhupus 15
Evidence of immune response to BNT162b2 COVID-19 vaccine in systemic lupus erythematosus patients treated with Belimumab 12
Membrane and Soluble CD137 in Systemic Lupus Erythematosus: Role as Biomarkers for Disease Activity 10
Erosive arthritis in systemic lupus erythematosus: application of cluster analysis 7
The Impacts of the Clinical and Genetic Factors on Chronic Damage in Caucasian Systemic Lupus Erythematosus Patients 6
Science and visual arts: binomial or dichotomy. a pilot study in systemic lupus erythematosus patients 5
Fever in systemic lupus erythematosus: associated clinical features and genetic factors 5
Organ damage in Systemic Lupus Erythematosus patients: A multifactorial phenomenon 2
Totale 665
Categoria #
all - tutte 2.983
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.983


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 0 0 0 0 0 0 0 2
2020/202171 3 0 0 0 0 1 0 15 9 3 17 23
2021/2022200 17 6 14 23 24 15 2 8 18 9 41 23
2022/2023216 28 50 16 21 17 23 5 20 20 5 11 0
2023/2024169 7 17 5 9 9 20 15 2 13 30 28 14
2024/20257 7 0 0 0 0 0 0 0 0 0 0 0
Totale 665